Skip to Content
Cancer Helpline
800.227.2345
Live Chat
Sign Up For Email
American Cancer Society
  • Español
  • More Languages
Give In Honor & Memorial Donate
Give In Honor & Memorial Donate
  • Cancer A-Z
  • Stay Healthy
  • Treatment & Support
  • News
  • Our Research
  • Get Involved
  • Our Partners
  • About Us
Cancer Helpline
800.227.2345
Live Chat
Sign Up For Email
Search
Category
En Español

Latest News

Our team of expert journalists brings you all angles of the cancer story – from breaking news and survivor stories to in-depth insights into cutting-edge research.

Filtering by:

Targeted Therapy
Top Story
Read More
December 6, 2019

2019 in Review: New Cancer Drug Approvals

In 2019, the FDA approved several new drug treatments for different cancer types. Here are the stories that made headlines on cancer.org this year.

FDA, Immunotherapy, Living Well, Targeted Therapy, Treatment
Share
Facebook Twitter
Read More
November 1, 2019

Cancer Patients May Not Be Told About Costs of Genomic Testing

As of 2016, more than 200 targeted therapies (also called precision medicines) were available in the United States, and more than 2,000 were in the last stages of development—half of them to treat cancer. For many of these drugs, doctors first use genomic testing of the cancer cells to get an idea of whether the treatment will work. Yet, nearly 1 in 4 oncologists rarely or never mention costs when they talk about the need for genomic testing with their cancer patients, according to a new study led by American Cancer Society (ACS) investigators.

ACS Research, Genetics, Insurance, Paying for Care, Targeted Therapy
Share
Facebook Twitter
August 30, 2019

FDA Approves Rozlytrek (Entrectinib) for Tumors With Certain Genetic Markers

The US Food and Drug Administration (FDA) has approved Rozlytrek (entrectinib) for adults and adolescents with tumors that test positive for NTRK gene changes, which can help cancerous tumors grow.

Cancer Updates, FDA, Genetics, Targeted Therapy
Share
Facebook Twitter
June 12, 2019

FDA Approves Polivy (Polatuzumab Vedotin-piiq) for Lymphoma

The US Food and Drug Administration (FDA) has approved the antibody-drug conjugate Polivy (polatuzumab vedotin-piiq) to treat people with diffuse large B-cell lymphoma (DLBCL).

Cancer Updates, FDA, Lymphoma, Non-Hodgkin Lymphoma, Targeted Therapy
Share
Facebook Twitter
May 29, 2019

FDA Approves First PI3K Inhibitor for Breast Cancer

The US Food and Drug Administration (FDA) has approved the first treatment of its kind for a certain type of breast cancer caused by an inherited genetic mutation. Piqray (alpelisib) is a targeted therapy called a PI3K inhibitor.

Breast Cancer, Breast Cancer in Men, Cancer Updates, FDA, Targeted Therapy
Share
Facebook Twitter
April 16, 2019

FDA Approves First Targeted Therapy for Bladder Cancer

The US Food and Drug Administration (FDA) has approved Balversa (erdafitinib) as the first targeted therapy for bladder cancer.

Bladder Cancer, Cancer Updates, FDA, Targeted Therapy
Share
Facebook Twitter
Read More
December 28, 2018

2018 in Review: New Cancer Drug Approvals

In 2018, the FDA approved several new drug treatments for different cancer types that American Cancer Society editors believe will make a significant difference.

FDA, Immunotherapy, Living Well, Targeted Therapy, Treatment
Share
Facebook Twitter
December 10, 2018

New Drug Reduces Recurrence Risk for Some Women With Early-Stage Breast Cancer

Research presented at the San Antonio Breast Cancer Symposium may result in a new standard of care for some people with HER2 positive, early stage breast cancer.

Breast Cancer, Cancer Updates, Chemotherapy, Targeted Therapy
Share
Facebook Twitter
Load More Results
Latest News
Cancer Updates
Living Well
ACS Research
Stories of Hope
Special Coverage

Featured Topics

Breast CancerVaccinationsColon and Rectal Cancer
  • Cancer Topics
  • Cancer Types

More Cancer News

read more
Cancer Facts and Statistics

Get the most current information about cancer

read more
Dr. Len's Blog

Perspectives on cancer news from our deputy chief medical officer

Read More
ACS Press Room

Our one-stop-shop for the media

BackTo Top

Imagine a world free from cancer. Help make it a reality.

DONATE

Cancer Information

  • Cancer Prevention & Detection
  • Cancer Basics
  • Signs & Symptoms of Cancer
  • Treatments & Side Effects
  • Cancer Facts & Statistics
  • News and Stories
  • Glossary
  • For Health Care Professionals

Programs & Services

  • Breast Cancer Support
  • TLC Hair Loss & Mastectomy Products
  • Hope Lodge® Lodging
  • Rides To Treatment
  • Online Support Communities

ACS FUNDRAISERS

  • Making Strides Against Breast Cancer Walks
  • Relay For Life Events
  • College Relay For Life
  • Coaches vs. Cancer
  • Galas, Balls & Parties
  • Ways to Give
  • Memorial Giving
  • Planned Giving
  • Leadership Giving
  • Donate a Car

About ACS

  • Contact Us
  • Local Offices
  • Employment
  • Information for Suppliers
  • Report Fraud or Abuse
  • Global Health
  • ACS CAN
  • Sign Up for Email
  • Policies
  • Our Volunteers

More ACS Sites

  • Bookstore
  • Cancer Atlas
  • Press Room
  • Cancer Statistics Center
  • Volunteer Learning Center

Follow Us

Twitter Facebook Instagram

Cancer Information, Answers, and Hope. Available Every Minute of Every Day.

800.227.2345

Live Chat

Follow Us

Twitter Facebook Instagram
  • help
  • site map
  • privacy policy - 2018
  • accessibility
  • terms of use
  • state fundraising notices
  • Site Comments

© 2019 American Cancer Society, Inc. All rights reserved. The American Cancer Society is a qualified 501(c)(3) tax-exempt organization. Cancer.org is provided courtesy of the Leo and Gloria Rosen family.

*
Image of
Previous Next
Close

Select A Hope Lodge

Close
Woman in black scarf facing camera
Your help makes breakthrough research, free rides to treatment, free places to stay near hospitals, and other crucial patient services all possible.
$50
$75
$125

Other

$
Donate

Your gift is 100% tax deductible

No, Thanks